mdpi.com
A recent study examines how gene variations in the vitamin D binding protein may influence the outcomes of total hip replacement surgeries, with implications for patient care and prosthesis stability.
The study investigates how polymorphisms in the vitamin D binding protein gene affect the success and stability of total hip replacements, focusing on the risk of prosthesis loosening.
Research highlights a potential connection between vitamin D binding protein gene variants and hip replacement outcomes, suggesting that higher levels of 25(OH)D might reduce the risk of prosthesis loosening. Genetic factors such as the rs4588 SNP appear to increase this risk, underscoring the importance of preoperative biochemical and genetic screening.
Vitamin D plays a significant role in bone health, primarily by aiding calcium absorption and bone mineralization. It is carried in the bloodstream by vitamin D binding proteins (VDBP), whose levels and effectiveness can be affected by genetic variations, particularly single nucleotide polymorphisms (SNPs) like rs4588 and rs7041.
This study aimed to analyze the association between these SNPs, serum levels of VDBP and 25(OH)D, and their potential roles in THR outcomes.
The presence of these polymorphisms may lead to varied blood levels of 25(OH)D, potentially influencing the stability of a hip prosthesis post-surgery. As such, understanding these genetic variations could be key in optimizing surgical outcomes.
The study found significant variations in VDBP and 25(OH)D levels across patient groups, suggesting a genetic influence on these parameters. Specifically, the presence of the rs4588 SNP was linked to increased risk of prosthesis loosening, highlighting the importance of genetic screening.
Haplotype analysis showed that the G/T haplotype was more frequent in the L group, while the G/G haplotype was less common.
These findings suggest that by testing for specific SNPs, healthcare providers can better predict which patients are more likely to experience complications, allowing for tailored interventions and monitoring.
By assessing both genetic and biochemical markers preoperatively, clinicians could stratify patients based on their risk of implant instability. This involves more frequent monitoring for signs of loosening and earlier intervention for those at higher risk.
The negative correlation between VDBP and 25(OH)D associated with higher VDBP levels in orthopedic patients indicates an adaptive mechanism in response to vitamin D deficiency.
The integration of genetic screening into routine preoperative assessments could thus represent a significant step forward in personalized medicine, improving patient outcomes in orthopedic surgery.
Rozmus, D.; Fiedorowicz, E.; Płomiński, J.; Cieślińska, A. Vitamin D Binding Protein Gene Polymorphisms (rs4588 and rs7041) and VDBP Levels in Total Hip Replacement Outcomes. Nutrients 2025, 17, 378.
OECD. (2024). Number of hip replacement surgeries in select countries in 2021 (per 100,000 population). Statista. Retrieved January 22, 2025, from https://www.statista.com/statistics/283234/number-of-knee-replacements-in-selected-countries/
Yang, Q.; Wang, J.; Xu, Y.; Chen, Y.; Lian, Q.; Zhang, Y. Incidence and Risk Factors of In-Hospital Prosthesis-Related Complications Following Total Hip Arthroplasty: A Retrospective Nationwide Inpatient Sample Database Study. Int. Orthop. 2020, 44, 2243–2252.